This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (13)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Jae C. Chang, MD; Joseph Appleby, MT; John M. Bennett, MD

Arch Intern Med. 1974;133(3):401-403.

Abstract
A nitroblue tetrazolium (NBT) test showed positive reactions in all of 22 patients with Hodgkin disease and in nine of 12 patients with malignant lymphoma. No correlation was noted in the degree of NBT reduction, activity of the diseases, presence of fever, leukocytosis, stage of the diseases, or treatment modality. Patients with Hodgkin disease and malignant lymphoma may retain an enhanced phagocytic and bactericidal activity in response to unknown stimuli.

Author Affiliations
Rochester, NY

From the Department of Medicine, University of Rochester School of Medicine and Dentistry, and the Hematology-Medical Oncology Unit, Highland Hospital, Rochester, NY.

Footnotes
Received for publication Nov 8, 1972; accepted Jan 23, 1973.

Reprint requests to Highland Hospital, South Ave and Bellevue Dr, Rochester, NY 14620 (Dr. Bennett).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?